What do patients with chronic non-cancer pain know about the opiates that they are prescribed?

¿Qué saben los pacientes con dolor crónico no oncológico sobre los opioides que les formulan?

Article Sidebar


PDF (Español (España)) FLIP

How to Cite
Buitrago, C. L., Amaya, D. M., & Pérez, M. A. (2016). What do patients with chronic non-cancer pain know about the opiates that they are prescribed?. Journal of Medicine and Surgery Repertoire, 25(2), 95–100. Retrieved from https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/87
Published: Jun 1, 2016
Issue
Vol. 25 No. 2 (2016): April - June
Section
Review Articles
License terms

   

Main Article Content

Claudia Liliana Buitrago
Daniela Marcela Amaya
Miguel Antonio Pérez

Abstract

Introduction: As pain is the leading reason for medical consultation worldwide, the use of opioids in the management of non-cancer related chronic pain has increased, and poor patient knowledge has led to opioid misuse.
Objective: We describe the risks, adverse effects, attitudes, and practices of out-patients prescribed with opioids for non-cancer related chronic pain in a fourth level hospital in Bogotá DC, Colombia. A two-phase descriptive cross-sectional study was conducted. First, a questionnaire, approved by an evaluating panel, was constructed using the Delphi methodology. Second, the questionnaire was applied in the study population: 81 patients between September and December 2014; females 71.6%, mean age 56.6 years (SD: 15.2), and back pain (34.6%) being the most frequent diagnosis. The most commonly prescribed opioid medication was hydrocodone (24.1%).
Results: The most commonly recognised side effect was constipation (60.5%); 28.4% do not know if driving is restricted, and 34.6% believe driving is allowed; 6.5% again consulted again due to persistent pain. 23.5% keep the remaining medication after it is changed or stopped, while 9.9% gives it to someone else.
Conclusions: Poor patient knowledge on restricted activities, potential side effects and proper opioid medication disposal was detected.

Keywords:

Downloads

Download data is not yet available.

Article Details

References

1. Mitra R. The utilization of opiates in pain management: use or abuse. Eur J Phys Rehabil Med. 2013;49:93–6.

2. Walid MS, Donahue SN, Darmohray DM, Hyer LA, Robinson JS. The fifth vital sign–what does it mean? Pain Pract. 2008;8:417–22.

3. Saruwatari Zavala G, Siqueiros-García JM. El alivio del dolor: ¿es un derecho humano? Rev Soc Esp Dolor. 2012;19:147–56.

4. Finch JW. Challenges of chronic pain management: public health consequences and considered responses. N C Med J. 2013;74:243–5, 7-8.

5. Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol. 2012;8:387–92.

6. Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010;11:1230–9.

7. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333.

8. Ricardo D, Felipe M. Dolor crónico nociceptivo y neuropático en población adulta de Manizales (Colombia). Acta Medica Colombiana. 2011;36:10–7.

9. Hambleton S. Opioids for chronic noncancer pain: are they safe and effective? J Miss State Med Assoc. 2013;54:4–7.

10. Cheatle MD, Barker C. Improving opioid prescription practices and reducing patient risk in the primary care setting. J Pain Res. 2014;7:301–11.

11. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15:Es67–92.

12. Ballantyne JC. “Safe and effective when used as directed”: the case of chronic use of opioid analgesics. J Med Toxicol. 2012;8:417–23.

13. Pohl M, Smith L. Chronic pain and addiction: challenging co-occurring disorders. J Psychoactive Drugs. 2012;44:119–24.

14. Wallace LS, Wexler RK, Miser WF, McDougle L, Haddox JD. Development and validation of the Patient Opioid Education Measure. J Pain Res. 2013;6:663–81.

15. Network NCC. National comprehensive cancer network http://www.nccn.org/: Copyright (2015 National Comprehensive Cancer Network; 2014 [cited 2015 JAN]. 2014:[NCCN].

16. Jho HJ, Kim Y, Kong KA, Kim DH, Choi JY, Nam EJ, et al. Knowledge, practices, and perceived barriers regarding cancer pain management among physicians and nurses in Korea: a nationwide multicenter survey. PLoS One. 2014;9:e105900.

17. Bloodworth D. Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations. Phys Med Rehabil Clin N Am. 2006;17:355–79.

18. Doubova SV, Mino-León D, Torres-Arreola LdP, Romero-Quechol G. Conocimiento básico de los riesgos del uso de analgésicos no opioides en pacientes ambulatorios. Salud Pública de México. 2007;49:429–36.

19. Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776–82.

20. Tanner S, Wells M, Scarbecz M, McCann BW. Parents’ understanding of and accuracy in using measuring devices to administer liquid oral pain medication. J Am Dent Assoc. 2014;145:141–9.

Citado por